Clinical Trial Update: Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating esomeprazole magnesium (Nexium) for potential anti-asthmatic effects in asthma with GERD. Results were posted on 2014-06-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Gastroesophageal Reflux Disease

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, GERD | Phase 2 | Status: COMPLETED | Results posted: 2014-06-09